Michael Sextro
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 10
-
- Hematopoietic Stem Cell Transplantation 1
- Co-authors
- Volker Diehl (8 shared papers)Dirk Hasenclever (5 shared papers)Hartmut H. Kirchner (2 shared papers)Norbert Schmitz (2 shared papers)Markus Sieber (1 shared paper)Andreas Lohri (1 shared paper)Beate Pfistner (1 shared paper)Susanne Decker (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)Annals of Hematology (2 papers)Blood (1 paper)The Lancet (1 paper)
- Partner nations
- GermanyUnited KingdomItaly
In The Last Decade
Michael Sextro
13 papers receiving 1.9k citations
Michael Sextro's Hit Papers
Peers
Comparison fields: 5 of 35
- Pathology and Forensic Medicine 1.5k
- Hematology 175
- Oncology 88
- Immunology 14
- Genetics 5
Countries citing papers authored by Michael Sextro
This map shows the geographic impact of Michael Sextro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sextro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sextro more than expected).
Fields of papers citing papers by Michael Sextro
This network shows the impact of papers produced by Michael Sextro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sextro. The network helps show where Michael Sextro may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Sextro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Hit paper breakdown → | 2002 | 909 |
| 2 | 1999 | 291 | |
| 3 | 2000 | 212 | |
| 4 | 1998 | 172 | |
| 5 | 1998 | 148 | |
| 6 | 2000 | 89 | |
| 7 | Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. | 1997 | 60 |
| 8 | Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. | 1996 | 43 |
| 9 | 1998 | 33 | |
| 10 | 1996 | 20 | |
| 11 | 2001 | 11 | |
| 12 | 2000 | 9 | |
| 13 | 1998 | 7 |
About Michael Sextro
Michael Sextro is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 13 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Hematopoietic Stem Cell Transplantation (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Hematology (175 citations), Oncology (88 citations), Immunology (14 citations) and Genetics (5 citations). Michael Sextro has collaborated with scholars based in Germany, United Kingdom and Italy. Frequent co-authors include Volker Diehl, Dirk Hasenclever, Hartmut H. Kirchner, Norbert Schmitz, Markus Sieber, Andreas Lohri, Beate Pfistner, Susanne Decker, Reinhart Zschaber and Peter E. Müller. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Annals of Hematology, Blood and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.